Fifth EyeNews PagePress Release Fifth Eye Receives FDA Clearance to Market AHI System™ Fifth Eye™, a provider of intuitive real-time clinical analytics, today announced the FDA provided clearance…Casey FrushourJanuary 31, 2022
EQRxNews Page EQRx Announces Two Lancet Oncology Publications of Positive Phase 3 Results EQRx, Inc. (Nasdaq: EQRX) a new type of pharmaceutical company committed to developing and delivering…Casey FrushourJanuary 18, 2022
EQRxNews Page EQRx Enters Memorandum of Understanding with CVS Health to Create Cost Savings and Improve Patient Access to Innovative Medicines EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering…Casey FrushourJanuary 10, 2022